Erlotinib is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlotinib is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells. Common Side effects are acne, Conjunctivitis, Dry skin, Gastrointestinal bleeding, Hair follicle inflammation, Hair loss, Nosebleeds, Skin fissures, Corneal inflammation, Paronychia, Renal insufficiency.
